Full-Time

Technical Sales Manager TNAC / Virusys

Posted on 5/11/2026

LGC Group

LGC Group

1,001-5,000 employees

Sells oligos, probes, primers, viral materials

No salary listed

Remote in USA

Remote

Category
Sales & Account Management (1)
Required Skills
Sales
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in a biological field (e.g., Immunology, Virology, Molecular Biology, Biochemistry) and Master’s or Ph.D. preferred
  • Hands-on experience with Immunoassays (e.g., ELISA, lateral flow) or protein based workflows
  • Prior experience in technical sales, account management, or customer-facing scientific support preferred
  • Strong computer skills required, with a working knowledge of Microsoft Office suite of products, particularly Word, Excel, and PowerPoint
  • Self-motivated, goal-oriented, and comfortable working in a fast-paced, results-driven environment
  • Ability to work remotely and manage multiple priorities effectively
Responsibilities
  • Prospecting & Business Development: Identify and develop new sales opportunities across biopharma, diagnostics manufacturers, CROs, and academic institutions.
  • Prospecting & Business Development: Expand existing customer relationships by uncovering additional applications for TNAC reagents (e.g., assay development, QC, vaccine R&D).
  • Prospecting & Business Development: Drive revenue growth through proactive outreach including targeted account strategies, cold calls, email campaigns, and virtual engagement.
  • Prospecting & Business Development: Map key accounts involved in immunoassay development, infectious disease testing, and biologics development.
  • Technical Sales & Customer Engagement: Deliver technical presentations and product demonstrations focused on TNAC reagents, including antigens, antibodies, and viral proteins.
  • Technical Sales & Customer Engagement: Understand and address customer challenges related to assay sensitivity/specificity, reagent consistency, and supply chain reliability.
  • Technical Sales & Customer Engagement: Provide consultative support for reagent selection in applications such as: ELISA and lateral flow assay development; Neutralization and binding assays; Vaccine and therapeutic research; Diagnostic kit manufacturing.
  • Technical Sales & Customer Engagement: Translate complex biological and biochemical concepts into clear value propositions for diverse stakeholders.
  • Account Management & Support: Build and maintain strong customer relationships to ensure retention and long-term partnership growth.
  • Account Management & Support: Collaborate cross-functionally with product management, R&D, and operations to align on customer needs, custom projects, and supply requirements.
  • Account Management & Support: Track and report sales activities, pipeline status, customer feedback, and market intelligence in CRM systems.
  • Account Management & Support: Support forecasting, pricing strategies, and contract negotiations.
  • Industry and Product Knowledge: Develop deep expertise in: Infectious disease biomarkers and viral proteins; Immunoassay workflows and reagent requirements; Biopharma and diagnostic manufacturing processes.
  • Industry and Product Knowledge: Maintain awareness of market trends (e.g., emerging pathogens, vaccine pipelines, assay modality shifts).
  • Industry and Product Knowledge: Effectively position LGC TNAC products against competitors in terms of quality, validation, and scalability.
  • Strategic & Market Development: Analyze market opportunities and identify high-growth segments (e.g., emerging infectious diseases, multiplex diagnostics, vaccine programs).
  • Strategic & Market Development: Contribute to go-to-market strategies, including new product launches and portfolio expansion.
  • Strategic & Market Development: Provide voice-of-customer (VOC) insights to inform product development and roadmap prioritization.
  • Other Duties as Assigned: Demonstrate flexibility and collaboration in supporting corporate initiatives and evolving business priorities.
  • Other Duties as Assigned: Represent LGC at conferences, trade shows, and customer site visits.
Desired Qualifications
  • Master’s or Ph.D. preferred
  • Prior experience in technical sales, account management, or customer-facing scientific support preferred

LGC Group provides life-sciences tools and services worldwide, including oligo components, probes, primers, recombinant viral materials, and proficiency-testing schemes for food safety. Its products support vaccine development, diagnostics, and therapies through mass spectrometry, immunoassays, and nucleic acid chemistry. It differentiates itself with a broad catalog of high-quality tools plus global proficiency-testing services and a wide customer base across diagnostics, healthcare, and pharma. Its goal is to improve healthcare outcomes and help create safer vaccines and treatments by delivering reliable tools and quality services.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1841

Simplify Jobs

Simplify's Take

What believers are saying

  • ChromaDex acquisition February 2026 adds 3,000 phytochemical standards boosting North America sales.
  • Irish Horseracing Board renews LGC contract through 2027 for equine anti-doping analysis.
  • CAD$100 million Canada synthesis center expands pharma research chemical capacity.

What critics are saying

  • Merck KGaA erodes LGC market share with bundled CRMs at lower prices by Q1 2027.
  • WADA 2026 protocol causes Fordham lab to lose 30% human sports testing to NSF by Q4 2026.
  • USFDA revokes Lexington accreditation May 2026, forfeiting $50M horse racing contracts to Eurofins.

What makes LGC Group unique

  • LGC's Informed-Sport certifies 440 products against 250+ banned substances using ISO 17025 labs.
  • Lexington facility expanded November 2016 for equine doping control and US supplements testing.
  • LoGiCal portfolio offers 3,000+ toxicology reference standards since 2012 launch.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at LGC Group who can refer or advise you

Benefits

Hybrid Work Options

Remote Work Options

Company News

LGC Group
Feb 26th, 2026
LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business

LGC Group strengthens its reference material portfolio and North American reach with the acquisition of the ChromaDex Reference Standards business. The acquisition further enhances LGC's ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. London, UK, 26 February 2026. LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today announced the acquisition of the ChromaDex Reference Standards portfolio from Niagen Bioscience (NASDAQ: NAGE). The acquisition expands LGC's reference materials offering and strengthens its commercial reach across North America. The acquisition brings an established portfolio of phytochemical reference materials for the dietary supplements industry into LGC, enabling direct engagement with a broad base of laboratory customers and strengthening LGC's ability to support pharmaceutical companies, testing laboratories, and food producers operating in regulated markets. Bruno Rossi, EVP & General Manager, LGC Standards, said: "The ChromaDex standards portfolio further enhances LGC's ability to support our pharmaceutical customers, testing laboratories, and food producers. Building on LGC's position as a world leader in reference materials and analytical standards, this acquisition expands our North American commercial reach and further supports customers in generating reliable data that safeguards product integrity and confidence across global supply chains." For over 25 years, the ChromaDex Reference Standards portfolio has been built on deep expertise in phytochemical characterisation and analytical verification. The portfolio includes over 3,000 phytochemical reference materials, spanning major classes such as alkaloids, flavonoids, terpenes, carotenoids, organic acids, stilbenoids, vitamins, and select botanicals and plant-based compounds. These materials are widely used to support ingredient verification, method development, authenticity testing, contamination detection, and routine quality control across complex global supply chains. Rob Fried, CEO of Niagen Bioscience, remarked, "This transaction reflects our disciplined focus on what we do best - advancing NAD+ science and delivering clinically proven, patented Niagen(R) solutions across consumer and clinical channels. Selling Reference Standards to LGC is a meaningful step in simplifying our business and ensuring we are allocating capital and talent toward the highest-impact opportunities for shareholders." The acquisition of the ChromaDex Reference Standards portfolio demonstrates LGC's commitment to providing trusted reference materials and measurement solutions that reinforce product safety, quality, and regulatory confidence, advancing its mission of Science for a Safer World. LGC is a global leader in life sciences, diagnostics, and analytical solutions. LGC Group work with partners around the world to address some of society's most important challenges, from diagnosing disease and enabling new treatments to supporting food security and protecting public health. Its science supports discovery, enables better health outcomes and helps safeguard the integrity of food, water, medicines and the environment. Every day, LGC Group provide the components, standards and services that laboratories, manufacturers and regulators rely on to make confident, evidence-based decisions. With operations in 14 countries and more than 180 years of scientific expertise, its work supports public health and sustainability at a global scale. From improving the accuracy of medical testing and verifying the safety of food products, to helping scientists develop the next generation of medicines, its solutions are trusted by customers in more than 170 countries. For further information please contact: Customer contact: Richard Pembrey Sales Director, LGC Standards +1 603 851 2834 Media contact: Magda Bartoszewicz Director Corporate Brand and Communications, LGC Group +44 7408 850 514

CHEManager
Sep 12th, 2025
LGC Opens $100 Million Pharma Synthesis Center in Canada

LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, canada, significantly expanding global capacity for advanced research chemicals to support the pharmaceutical and life sciences sectors.

Graham B Jackson (Aust) Pty Ltd
Apr 15th, 2025
Ensuring Precision in Analysis: Graham B Jackson Pty Ltd Supply of LGC Certified Reference Materials

Graham B Jackson Pty Ltd (GBJPL), an Australian leader in reference materials, partners with the globally renowned LGC Group to supply high-quality CRMs to laboratories across the country.

Health Technology Insights
Apr 4th, 2025
Laboratory Proficiency Testing Market to Reach $2.1 Billion by 2030

For example, LGC Group introduced a proficiency testing (PT) service in April 2020 that uses nucleic acid amplification testing to identify SARS-CoV-2 (COVID-19).

Investors in Healthcare
Jan 10th, 2025
UK: LGC appoints Joydeep Goswami as president and CEO

UK-based LGC, an international life sciences measurement and tools company, has appointed Joydeep Goswami as president and CEO, succeeding Euan O'Sullivan, who decided to step down from his role in early 2024 after fourteen years of service.